DWTX
Dogwood Therapeutics, Inc.
$1.41
-0.03 (-2.08%)
At close · Jul 8
Market Cap
$47.42M
Shares
33,629,553
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$1.41
Open$1.41
Day$1.35–1.45
52W$1.28–9.50
Avg vol 30d98K
Short int27K · 0.1% float · 1.0d
Short vol65%
Last earningsMay 14, 2026
DataDec 2020–Jul 2026
Filing10-Q · May 15
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−60%
below
Price vs 50-day avg
−11%
below
RSI (14)
42
neutral
MACD trend
Negative
52-week position
2%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−3%
trailing
6-month return
−47%
trailing
YTD return
−66%
this year
Relative strength
−55%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $4 — 200d above 50d
Institutional flow
Accumulating
+30% holders QoQ · +6 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.08% of float · ▼ -58.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
13 holders — mid 1-yr range
Squeeze score
16
low risk · 0–100
Fundamentals
EPS growth
+43%
Y/Y
Valuation
P/E 1.2
below peers
Balance sheet
$6.5M
net cash
Quant / Vol
risk profile
Volatility
96%
annualized · 1-yr
Max drawdown
−83%
past year
ATR
10.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
Next earnings call
Dec 24, 2026
Est · unconfirmed
· in 24 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−60%
Bearish
Price vs 50-day avg
−11%
Bearish
RSI (14)
42
Neutral
MACD trend
Negative
Bearish
52-week position
2%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $2 › 200d $4 — 200d above 50d
Institutional flow
Accumulating
+30% holders QoQ · +6 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.08% of float · ▼ -58.6% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
13 holders — mid 1-yr range
Price context
position in its 52-week range
52-wk low $1
Now $1 · 2%
52-wk high $10
vs 200-day avg -60%
vs 50-day avg -11%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
DWTX
this stock
Dogwood Therapeutics, Inc.
|
$47.42M | -66.1% | — | 1.2 | 0.1% |
|
ONC
BeOne Medicines Ltd.
|
$437.67B | -0.6% | +22179.2% | 890.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$126.01B | +9.9% | +46.2% | 29.5 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$70.03B | -14.0% | +20.8% | 16.3 | 3.2% |
|
ARGX
Argenx SE
|
$56.84B | +8.8% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| DWTX | -12.4% | -3.4% | -47.2% | -12.4% | -66.1% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | -12.2% | -4.3% | -54.6% | -12.2% | -75.4% |